Proactive Investors - Run By Investors For Investors

Empower Clinics rises as it announces plans for hemp-based cannabidiol extraction facility in Oregon

The medical cannabis company said in a statement that it has entered a tentative deal to buy and license extraction equipment from Aibeida LifeTech
Marijuana leaves and medicinal bottles
The CBD extraction facility in Portland is due to open in the second quarter

Empower Clinics Inc (OTCMKTS:EPWCF) (CSE:EPW) soared Thursday as it announced plans to open a hemp-based cannabidiol extraction facility in the Portland, Oregon, area during the second quarter.

The medical cannabis company said in a statement that it has entered a tentative deal to buy and license extraction equipment from Aibeida LifeTech Ltd. The first system is expected to have the capacity to produce 6,000 kilograms of extracted product per year.

Shares of Empower Clinics jumped 5% to C$0.10 in Thursday’s Canadian trading and rocketed 35% to US$0.10.

READ: Empower Clinics to partner with Datametrex on a pilot artificial intelligence program

"Achieving vertical integration has been an objective of mine from the outset as we attempt to connect the science behind hemp-derived CBD based therapies and the efficacy of physician recommended treatment options made available through our clinic network, online or through retail partnerships," Empower CEO Steven McAuley said.

Shuang Xie, Aibeida's director and chief scientist, will oversee and manage the Empower CBD extraction facility.

Under the proposed terms, Empower will pay Aibeida US$1 million in cash at closing as well as a US$250,000 USD performance holdback, for a total cash payment of US$1.25 million. 

In addition, Empower will issue Aibeida common shares valued at US$1 million as well as additional shares having an aggregate value of US$1 million and vesting in quarterly installments over 36 months following closing.

The consideration is expected to be based on a deemed price per share equal to the 10-day volume-weighted average closing price on the Canadian Securities Exchange on the last business day before closing.

Earlier this week Empower Clinics announced that it intends to partner with Datametrex AI Limited (TSX:DM) and its subsidiary Canntop AI Inc to use artificial intelligence to analyze patient data.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full EPW profile View Profile

Empower Clinics Inc. Timeline

Related Articles

data graphic
Fri
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
cannabis extract
January 16 2019
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use